Literature DB >> 21528267

Overexpression of activin A inhibits growth, induces apoptosis, and suppresses tumorigenicity in an androgen-sensitive human prostate cancer cell line LNCaP.

Z Zhang1, J Zheng, Y Zhao, G Li, Y Batres, M Luo, M Wan, S Ying.   

Abstract

The effects of overexpression of activin A in the androgen-sensitive human prostate cancer cell line LNCaP were studied. A full-length cDNA of activin beta A coding region was inserted into a eukaryotic expression vector and transfected into the LNCaP cells. Overexpression of activin BA significantly inhibited growth of this cell line. An increased death rate was also noted in these activin-overproducing cells, which was believed to be due to apoptosis as manifested by morphological change, DNA laddering, and FAGS analysis. The expression of bcl-2 was suppressed and the expression of c-myc was stimulated in these cells. In addition, the efficiency of soft agar colony formation and the tumorigenicity in the nude mice were suppressed for the activin producing LNCaP cells.

Entities:  

Year:  1997        PMID: 21528267     DOI: 10.3892/ijo.11.4.727

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor.

Authors:  R C Wu; X Li; A H Schönthal
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

2.  Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis.

Authors:  Jian Sun; Xuan Liu; Hong Gao; Long Zhang; Qing Ji; Ziyuan Wang; Lihong Zhou; Yan Wang; Hua Sui; Zhongze Fan; Qi Li
Journal:  Oncotarget       Date:  2017-02-14

3.  Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers.

Authors:  Liqin Zhao; Jieyun Zhang; Xiaofei Qu; Ya'nan Yang; Zhe Gong; Yue Yang; Zhenhua Wu; Weijian Guo
Journal:  Onco Targets Ther       Date:  2020-05-05       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.